Are you or a loved one currently being treated with buprenorphine medications such as SUBOXONE®, SUBUTEX®, BUNAVAIL®, or ZUBSOLV® for opioid dependence? Would you like to transition from buprenorphine to monthly non-opiod injectable naltrexone?
The Segal Institute for Clinical Research is currently conducting a clinical research study evaluating the safety and efficacy of an investigation medication for patients with opioid use disorder.
Qualified Participants Must:
Be between the ages of 18 and 60 (inclusive)
Have been diagnosed with opioid use disorder for at least 6 months
Be currently taking Buprenorphine (SUBOXONE, SUBUTEX, BUNAVAIL, or ZUBSOLV)
Qualified Participants May Receive:
- All study related exams, lab work and investigational study medication at no cost
- Complimentary transportation
- Compensation up to $1,850 for time and travel.